检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]桂林医学院附属医院内分泌科,广西桂林541001 [2]中南大学肿瘤研究所,湖南长沙410078
出 处:《安徽大学学报(自然科学版)》2016年第4期87-91,共5页Journal of Anhui University(Natural Science Edition)
基 金:国家自然科学基金资助项目(81260134;81560148);广西科技厅青年基金资助项目(2011GXNSFB018108)
摘 要:探讨PKCβ抑制剂(LY333531)对高糖高脂环境下系膜细胞分泌细胞外基质(ECM)的影响,单独培养人肾小球系膜细胞,实验分为对照组、LY333531组、高糖高脂组、高糖高脂+LY333531组.首先采用qRTPCR检测PKCβI的表达,然后通过ELISA法检测细胞上清液Col IV、Fn的含量.结果显示,高糖高脂组相较于对照组,PKCβI mRNA的表达水平明显增加(P<0.05),LY333531可以明显抑制PKCβI的表达(P<0.05);高糖高脂组相较于对照组,细胞上清液Col IV、Fn含量明显增加(P<0.05),而这种作用可被LY333531所抑制(P<0.05).表明高糖高脂可通过促进系膜细胞PKCβI表达从而诱导ECM的分泌,增加肾纤维化发生的风险,而LY333531可明显抑制这种作用.To investigate the effect of PKCβ inhibitor (LY333531) on extracellular matrix (ECM) of masangial cells in high glucose (HG) and lysophosphatidylcholine (LPC) environment, human mesangial cells (HMCs) were cultured alone and divided into 4 groups: control; LY333531; HG and LPC(HG+LPC) ; HG, LPC and LY333531 (HG+ LPC+ LY333531). First, we used the method of quantitative real-time PCR(qRT-PCR) to detect the expression of PKCβI; then, the levels of collagen IV and fibronectin were detected by enzyme linked immunosorbent assay(ELISA) in the supernatant. These results suggested that the mRNA expression of PKCβI in the group of HG+LPC was higher than the control group (P〈0.05), and the effect could be obviously inhibited by LY333531 (P〈0. 05). Meanwhile, compared with the control group, the level of collagen IV and fibronectin in the supernatant was significantly increased in the could be also inhibited by LY333531 notably group of HG+LPC (P〈0. 05), and the effect (P〈0. 05) Thorefore,we could conclude that the HG+LPC can aggrandize the secretion of ECM by increasing the expression of PKCβI in mesangial cells, which can increase the risk of renal fibrosis, however, LY333531 can weaken the effect obviously.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49